[go: up one dir, main page]

AU5374898A - The use of oxandrolone in the treatment of chronic fatigue syndrome - Google Patents

The use of oxandrolone in the treatment of chronic fatigue syndrome

Info

Publication number
AU5374898A
AU5374898A AU53748/98A AU5374898A AU5374898A AU 5374898 A AU5374898 A AU 5374898A AU 53748/98 A AU53748/98 A AU 53748/98A AU 5374898 A AU5374898 A AU 5374898A AU 5374898 A AU5374898 A AU 5374898A
Authority
AU
Australia
Prior art keywords
oxandrolone
treatment
chronic fatigue
fatigue syndrome
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53748/98A
Inventor
Jon D. Kaiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JON D KAISER
Original Assignee
JON D KAISER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JON D KAISER filed Critical JON D KAISER
Publication of AU5374898A publication Critical patent/AU5374898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53748/98A 1996-12-05 1997-12-05 The use of oxandrolone in the treatment of chronic fatigue syndrome Abandoned AU5374898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3241896P 1996-12-05 1996-12-05
US60032418 1996-12-05
PCT/US1997/022336 WO1998024452A1 (en) 1996-12-05 1997-12-05 The use of oxandrolone in the treatment of chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
AU5374898A true AU5374898A (en) 1998-06-29

Family

ID=21864859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53748/98A Abandoned AU5374898A (en) 1996-12-05 1997-12-05 The use of oxandrolone in the treatment of chronic fatigue syndrome

Country Status (2)

Country Link
AU (1) AU5374898A (en)
WO (1) WO1998024452A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489270B1 (en) 1999-01-07 2002-12-03 Daniel P. Vollmer Methods for enhancing wellbore treatment fluids
US6787659B2 (en) * 2001-12-11 2004-09-07 Barr Laboratories, Inc. Process for the production of oxandrolone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340586A (en) * 1991-04-12 1994-08-23 University Of Southern California Methods and formulations for use in treating oophorectomized women

Also Published As

Publication number Publication date
WO1998024452A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
AU6396598A (en) Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
EP1008383A4 (en) Lipoprotein adsorbent and lipoprotein adsorber made with the use of the same
AU1542895A (en) Surface treatment
AU3124295A (en) Surface treatment techniques
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU2418499A (en) Org-5222 in the treatment of depression
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
AU3697395A (en) Sitting and training surface
ZA973843B (en) Treatment of asthma with TNFR-lg.
AU3634595A (en) Bis-oxazolidines and their use
AU2160697A (en) Nsaids in the treatment of pruritus
AU3895300A (en) Treatment of chronic fatigue syndrome
AU5374898A (en) The use of oxandrolone in the treatment of chronic fatigue syndrome
AU4265996A (en) Disulphide-cyclo-(H-CYS-GLU-GLN-TYR-CYS-OH), and its use in blood-clotting disorders
AU4177196A (en) Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage
AU2004095A (en) Resin composition and multilayered structure comprising the same
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
AU4307397A (en) The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
AU2713797A (en) Depigmentating agent in the treatment of melasma
EP1032266A4 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
AU7622898A (en) The use of oxandrolone in the treatment of a neurological disorder
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
AU2973997A (en) Use of substituted azaspirane in the treatment of asthma
AU4266096A (en) Factor vii fragment 82-128 and its use in blood-clotting disorders
HK1020528A (en) Use ofsubstituted azaspirane in the treatment of asthma